Literature DB >> 22888093

Multivariate extreme value modelling of laboratory safety data from clinical studies.

Harry Southworth1, Janet E Heffernan.   

Abstract

Generally, in the interpretation of clinical safety laboratory data, it is extreme values that indicate potential safety issues. We illustrate the application of multivariate extreme value modelling to such data. Applying the methods to a clinical trial dataset, we find unexpected extremal relationships that have potentially important implications for the interpretation of such data.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Year:  2012        PMID: 22888093     DOI: 10.1002/pst.1531

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  3 in total

Review 1.  Methodology to assess clinical liver safety data.

Authors:  Michael Merz; Kwan R Lee; Gerd A Kullak-Ublick; Andreas Brueckner; Paul B Watkins
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

2.  Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial.

Authors:  Noel Patson; Mavuto Mukaka; Umberto D'Alessandro; Gertrude Chapotera; Victor Mwapasa; Don Mathanga; Lawrence Kazembe; Miriam K Laufer; Tobias Chirwa
Journal:  BMC Med Res Methodol       Date:  2021-10-09       Impact factor: 4.615

3.  Good Signal Detection Practices: Evidence from IMI PROTECT.

Authors:  Antoni F Z Wisniewski; Andrew Bate; Cedric Bousquet; Andreas Brueckner; Gianmario Candore; Kristina Juhlin; Miguel A Macia-Martinez; Katrin Manlik; Naashika Quarcoo; Suzie Seabroke; Jim Slattery; Harry Southworth; Bharat Thakrar; Phil Tregunno; Lionel Van Holle; Michael Kayser; G Niklas Norén
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.